natgillin/translations-raw huggingface dataset:
Pursuant to Article 29.1 of the Statute of the ESCB, each central bank which is a member of the European System of Central Banks is assigned a weighting in the key for subscription to the ECB’s capital, as laid down by Decision ECB/2008/23 of 12 December 2008 on the national central banks’ percentage shares in the key for subscription to the European Central Bank’s capital [3]; this weighting is based on the population and gross domestic product of each Member State and governs the contributions to the ECB’s capital, the transfers of the NCBs’ foreign reserve assets to the ECB, the monetary income allocation of the NCBs, and the distribution of profits and sharing of losses of the ECB.
Na podlagi člena 29.1 Statuta ESCB se za vsako centralno banko, ki je članica Evropskega sistema centralnih bank, določi ponder v ključu za vpis kapitala ECB, kakor določa Sklep ECB/2008/23 z dne 12. decembra 2008 o odstotnih deležih nacionalnih centralnih bank v ključu za vpis kapitala Evropske centralne banke [3]; ta ponder temelji na prebivalstvu in bruto domačemu proizvodu vsake države članice ter velja za vložke v kapital ECB, prenose deviznih rezerv NCB na ECB, razporeditev denarnih prihodkov NCB ter razdeljevanje dobička in delitev izgub ECB.
Euro banknotes are legal tender in all Member States whose currency is the euro and freely circulate within the euro area, are reissued by the Eurosystem members, and may also be stored or used outside the euro area.
Eurobankovci so zakonito plačilno sredstvo v vseh državah članicah, katerih valuta je euro, prosto krožijo v euroobmočju, članice Eurosistema jih ponovno izdajajo in se smejo hraniti ali uporabljati tudi zunaj euroobmočja.
The liabilities in respect of the issue of the total value of euro banknotes in circulation should therefore be allocated to the Eurosystem members in accordance with an objective criterion.
Obveznosti glede izdajanja celotne vrednosti eurobankovcev v obtoku je zato treba razdeliti med članice Eurosistema v skladu z objektivnim merilom.
An appropriate criterion is the share of each NCB in the paid-up capital of the ECB.
Ustrezno merilo je delež vsake NCB v vplačanem kapitalu ECB.
This share results from a proportional application of the capital key referred to in Article 29.1 of the Statute of the ESCB to NCBs.
Ta delež se dobi tako, da se za nacionalne centralne banke sorazmerno uporabi kapitalski ključ iz člena 29.1 Statuta ESCB.
As this criterion is not applicable to the ECB, the percentage share of euro banknotes to be issued by the ECB is to be determined by the Governing Council.
Ker za ECB tega merila ni mogoče uporabiti, Svet ECB določi odstotni delež eurobankovcev, ki jih izda ECB.
Under Articles 9.2 and 12.1 of the Statute of the ESCB, establishing the principle of decentralisation for Eurosystem operations, the NCBs are entrusted with putting into and withdrawing from circulation all euro banknotes including those issued by the ECB.
V skladu s členoma 9.2 in 12.1 Statuta ESCB, ki vzpostavljata načelo decentralizacije pri delovanju Eurosistema, so NCB pooblaščene za dajanje eurobankovcev v obtok in njihovo jemanje iz obtoka, vključno z bankovci, ki jih je izdala ECB.
Consistent with this principle, the physical handling of euro banknotes is also carried out by the NCBs.
Skladno s tem načelom NCB izvajajo tudi fizično obdelavo eurobankovcev.
The difference between the value of euro banknotes allocated to each NCB in accordance with the banknote allocation key and the value of the euro banknotes that such NCB puts into circulation should give rise to intra-Eurosystem balances.
Razlika med vrednostjo eurobankovcev, dodeljeno posamezni NCB v skladu s ključem za razdelitev bankovcev, in vrednostjo eurobankovcev, ki jih ta NCB da v obtok, povzroči saldo znotraj Eurosistema.
As the ECB does not put euro banknotes into circulation, it should hold intra-Eurosystem claims on NCBs for a value equivalent to the share of euro banknotes that it issues.
Ker ECB ne daje eurobankovcev v obtok, ima do nacionalnih centralnih bank terjatve znotraj Eurosistema v vrednosti, ki ustreza deležu eurobankovcev, ki jih izda.
The remuneration of these intra-Eurosystem balances has an effect on the income positions of NCBs and is therefore the subject of Decision ECB/2010/23 of 25 November 2010 on the allocation of monetary income of the national central banks of Member States whose currency is the euro [4], based on Article 32 of the Statute of the ESCB.
Obrestovanje tega salda znotraj Eurosistema vpliva na stanje prihodkov NCB in je zato predmet Sklepa ECB/2010/23 z dne 25. novembra 2010 o razporeditvi denarnih prihodkov nacionalnih centralnih bank držav članic, katerih valuta je euro [4], na podlagi člena 32 Statuta ESCB.
Pursuant to Article 1 of Council Decision 2010/416/EU of 13 July 2010 in accordance with Article 140(2) of the Treaty on the adoption by Estonia of the euro on 1 January 2011 [5], Estonia fulfils the necessary conditions for adoption of the euro and the derogation granted to it under Article 4 of the 2003 Act of Accession [6] will be abrogated with effect from 1 January 2011.
V skladu s členom 1 Sklepa Sveta 2010/416/EU z dne 13. julija 2010 v skladu s členom 140(2) Pogodbe o uvedbi eura v Estoniji 1. januarja 2011 [5] Estonija izpolnjuje potrebne pogoje za uvedbo eura, zato se bo odstopanje, ki ji je bilo odobreno v skladu s členom 4 Akta o pristopu iz leta 2003 [6], razveljavilo s 1. januarjem 2011.
‘euro banknotes’ means those banknotes complying with the requirements of Decision ECB/2003/4 and with the technical specifications laid down by the Governing Council;
„eurobankovci“ pomenijo bankovce, ki izpolnjujejo zahteve Sklepa ECB/2003/4 in tehnične specifikacije, ki jih določi Svet ECB;
‘subscribed capital key’ means the NCBs’ shares (expressed as percentages) in the ECB’s subscribed capital that result from applying to the NCBs the weightings in the key referred to in Article 29.1 of the Statute of the ESCB and as applicable for the relevant financial year;
„ključ za vpis kapitala“ pomeni deleže NCB (izražene v odstotkih) v vpisanem kapitalu ECB, dobljene tako, da se za NCB uporabijo ponderji v ključu iz člena 29.1 Statuta ESCB, ki veljajo v ustreznem poslovnem letu;
‘banknote allocation key’ means the percentages that result from taking into account the ECB’s share in the total euro banknote issue and applying the subscribed capital key (rounded to the nearest multiple of 0,0005 of a percentage point) to the NCBs’ share in this total.
„ključ za razdelitev bankovcev“ pomeni odstotke, dobljene tako, da se upošteva delež ECB v celotni izdaji eurobankovcev in pomnoži delež nacionalnih centralnih bank v tej celoti s ključem za vpis kapitala (zaokroženo na najbližji mnogokratnik 0,0005 odstotne točke).
Where the resulting percentages do not total 100 %, the difference shall be compensated for: (i) if the total is below 100 %, by adding 0,0005 of a percentage point to the smallest shares in ascending order until exactly 100 % is reached; or (ii) if the total is above 100 %, by subtracting 0,0005 of a percentage point in descending order from the largest shares until exactly 100 % is reached.
Če vsota dobljenih odstotkov ne znaša 100 %, se razlika izravna: (i) če je vsota manjša od 100 %, s prištevanjem 0,0005 odstotne točke najmanjšim deležem v naraščajočem zaporedju, dokler ni doseženo natančno 100 %, ali (ii) če je vsota večja od 100 %, z odštevanjem 0,0005 odstotne točke od največjih deležev v padajočem zaporedju, dokler ni doseženo natančno 100 %.
Annex I to this Decision specifies the banknote allocation key that shall apply from 1 January 2011.
Priloga I k temu sklepu podrobneje določa ključ za razdelitev bankovcev, ki se uporablja od 1. januarja 2011.
Issue of euro banknotes
Izdajanje eurobankovcev
The ECB and the NCBs shall issue euro banknotes.
Eurobankovce izdajajo ECB in NCB.
Obligations of issuers
Obveznosti izdajateljev
NCBs shall put into and withdraw from circulation euro banknotes, and perform any physical handling in relation to all euro banknotes, including those issued by the ECB.
NCB dajejo eurobankovce v obtok in jih jemljejo iz obtoka ter opravljajo vso fizično obdelavo vseh eurobankovcev, vključno s tistimi, ki jih izda ECB.
NCBs shall accept all euro banknotes on the request of the holder for exchange against euro banknotes of the same value or, in the case of account holders, to be credited to accounts held at the recipient NCB.
NCB na zahtevo imetnika sprejmejo vse eurobankovce v zamenjavo za eurobankovce v isti vrednosti ali, v primeru imetnika računa, za knjiženje v dobro računa, ki ga ima pri NCB prejemnici.
NCBs shall treat all euro banknotes accepted by them as liabilities and process them in an identical manner.
NCB obravnavajo vse sprejete eurobankovce kot obveznosti in jih obdelujejo na enak način.
NCBs shall not transfer euro banknotes accepted by them to other NCBs and shall keep such euro banknotes available for reissue.
NCB ne prenesejo sprejetih eurobankovcev na druge NCB in take eurobankovce hranijo na voljo za ponovno izdajo.
As an exception, and in accordance with any rules laid down by the ECB’s Governing Council:
Veljata naslednji izjemi, v skladu s pravili, ki jih določi Svet ECB:
mutilated, damaged, worn or withdrawn euro banknotes may be destroyed by the recipient NCB; and
NCB prejemnica sme uničiti okrnjene, poškodovane, obrabljene ali iz obtoka vzete eurobankovce; in
euro banknotes held by NCBs may, for logistical reasons, be redistributed in bulk within the Eurosystem.
eurobankovci, ki jih hranijo NCB, se smejo iz logističnih razlogov v večjih količinah prerazdeliti znotraj Eurosistema.
Allocation of euro banknotes within the Eurosystem
Razdelitev eurobankovcev znotraj Eurosistema
The total value of euro banknotes in circulation shall be allocated to the Eurosystem members by application of the banknote allocation key.
Celotna vrednost eurobankovcev v obtoku se razdeli med članice Eurosistema z uporabo ključa za razdelitev bankovcev.
The difference between the value of euro banknotes allocated to each NCB in accordance with the banknote allocation key and the value of the euro banknotes that such NCB puts into circulation shall give rise to intra-Eurosystem balances.
Razlika med vrednostjo eurobankovcev, dodeljeno posamezni NCB v skladu s ključem za razdelitev bankovcev, in vrednostjo eurobankovcev, ki jih ta NCB da v obtok, povzroči saldo znotraj Eurosistema.
The ECB shall hold intra-Eurosystem claims on NCBs in proportion to their shares in the subscribed capital key, for a value equivalent to the value of euro banknotes that it issues.
ECB ima za vrednost, enako vrednosti eurobankovcev, ki jih izda, terjatve znotraj Eurosistema do nacionalnih centralnih bank v sorazmerju z njihovimi deleži v ključu za vpis kapitala.
Decision ECB/2001/15 is repealed.
Sklep ECB/2001/15 se razveljavi.
References to the repealed Decision shall be construed as references to this Decision.
Sklicevanja na razveljavljeni sklep se razlagajo kot sklicevanja na ta sklep.
BANKNOTE ALLOCATION KEY FROM 1 JANUARY 2011
KLJUČ ZA RAZDELITEV BANKOVCEV OD 1. JANUARJA 2011
Decision ECB/2001/15
Sklep ECB/2001/15
OJ L 337, 20.12.2001, p. 52
UL L 337, 20.12.2001, str. 52.
Decision ECB/2003/23
Sklep ECB/2003/23
OJ L 9, 15.1.2004, p. 40
UL L 9, 15.1.2004, str. 40.
Decision ECB/2004/9
Sklep ECB/2004/9
OJ L 205, 9.6.2004, p. 17
UL L 205, 9.6.2004, str. 17.
Decision ECB/2006/25
Sklep ECB/2006/25
OJ L 24, 31.1.2007, p. 13
UL L 24, 31.1.2007, str. 13.
Decision ECB/2007/19
Sklep ECB/2007/19
OJ L 1, 4.1.2008, p. 7
UL L 1, 4.1.2008, str. 7.
Decision ECB/2008/26
Sklep ECB/2008/26
OJ L 21, 24.1.2009, p. 75
UL L 21, 24.1.2009, str. 75.
Given that Estonia will adopt the euro on 1 January 2011, Decision ECB/2001/15 of 6 December 2001 on the issue of euro banknotes [7] needs to be amended in order to determine the banknote allocation key applying from 1 January 2011.
Glede na to, da bo Estonija 1. januarja 2011 uvedla euro, je treba Sklep ECB/2001/15 z dne 6. decembra 2001 o izdajanju eurobankovcev [7] spremeniti tako, da se določi ključ za razdelitev bankovcev, ki se bo uporabljal od 1. januarja 2011.
Since Decision ECB/2001/15 has already been amended several times it should be recast in the interest of clarity,
Ker je bil Sklep ECB2001/15 že večkrat spremenjen, ga je treba zaradi jasnosti prenoviti –
(notified under document C(2009) 9703)
(notificirano pod dokumentarno številko C(2009) 9703)
Maxim’ and ‘Echinacea purpurea (L.)
Maxim“ in „Echinacea purpurea (L.)
Moench’ comply with the requirements set out in Directive 2001/83/EC.
Moench“ izpolnjujeta zahteve iz Direktive 2001/83/ES.
Moench’ can be considered as herbal substances, herbal preparations or combinations thereof.
Moench“ se lahko štejeta za rastlinski snovi, rastlinska pripravka ali kombinaciji obojega.
It is therefore appropriate to include ‘Eleutherococcus senticosus (Rupr. et Maxim.)
Zato je primerno, da se „Eleutherococcus senticosus (Rupr. et Maxim.)
Moench’ in the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products established in Annex I to Commission Decision 2008/911/EC [2].
Moench“ vključita v seznam rastlinskih snovi, pripravkov in njihovih kombinacij za uporabo v tradicionalnih zdravilih rastlinskega izvora v Prilogi I k Odločbi Komisije 2008/911/ES [2].
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use,
Ukrepi, predvideni s to odločbo, so v skladu z mnenjem Odbora za zdravila za uporabo v humani medicini –
Annex I is amended in accordance with Annex I to this Decision;
Priloga I se spremeni v skladu s Prilogo I k temu sklepu.
In Annex I to Decision 2008/911/EC, the following two substances are inserted after ‘Calendula officinalis L.’:
V Prilogo I k Odločbi 2008/911/ES se za „Calendula officinalis L“ vstavita snovi:
In Annex II to Decision 2008/911/EC, the following is inserted after the entry relating to ‘Calendula officinalis L’:
V Prilogo II k Odločbi 2008/911/ES se za vpisom „Calendula officinalis L“ vstavi:
‘COMMUNITY LIST ENTRY ON ECHINACEA PURPUREA (L.)
„VPIS V SEZNAM SKUPNOSTI ECHINACEA PURPUREA (L.)
Purple coneflower herb
Sveža zel škrlatne ehinaceje
Expressed juice and dried expressed juice from fresh flowering aerial parts.
Iztisnjeni sok in posušeni iztisnjeni sok iz svežih cvetočih nadzemnih delov.
N/A
Navedba smiselno ni potrebna.
Traditional herbal medicinal product for treatment of small superficial wounds.
Tradicionalno zdravilo rastlinskega izvora za zdravljenje manjših površinskih ran.
The product is a traditional herbal medicinal product for use in a specified indication exclusively based on long-standing use.
Izdelek je tradicionalno zdravilo rastlinskega izvora, namenjeno za uporabo pri navedenih indikacijah izključno na podlagi dolgotrajnih izkušenj.
European.
evropska
10 to 20 g/100 g of expressed juice or equivalent amount of dried expressed juice in liquid or semi-solid dosage forms.
10 do 20 g/100 g iztisnjenega soka ali enakovredna količina posušenega iztisnjenega soka v tekočih ali poltrdnih farmacevtskih oblikah.
Adolescents over the age of 12 years, adults, elderly
Mladostniki nad 12 let, odrasli, starejši
Small amount of ointment is applied on the affected area 2-3 times a day.
Manjša količina mazila se na prizadeto območje nanese 2–3-krat na dan.
The use in children under 12 years of age is not recommended (see below “Special warnings and precautions for use”).
Uporaba pri otrocih, mlajših od 12 let, ni priporočljiva (glej poglavje „Posebna opozorila in previdnostni ukrepi“).
Cutaneous use.
Dermalna uporaba.
Do not use the medicinal product for more than 1 week.
Zdravilo se ne sme uporabljati več kot 1 teden.
If the symptoms persist during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.
Če simptomi med uporabo zdravila ne popustijo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
Hypersensitivity to the active substance or to plants of the Asteraceae (Compositae) family.
Preobčutljivost na zdravilno učinkovino ali rastline iz družine nebinovk – Asteraceae (Compositae).
If signs of skin infection are observed, medical advice should be sought.
V primeru znakov okužbe kože je treba poiskati zdravniško pomoč.
The use in children below 12 years of age is not recommended because a safe use has not been sufficiently documented.
Uporaba pri otrocih, mlajših od 12 let, ni priporočljiva, ker varna uporaba ni bila zadostno dokazana.
There are no data on cutaneous use during pregnancy or lactation.
Ni podatkov o dermalni uporabi med nosečnostjo ali dojenjem.
Products containing Echinacea should not be applied to the breast of breastfeeding women.
Ženske, ki dojijo, si izdelkov, ki vsebujejo ehinacejo, ne smejo nanašati na prsi.
No studies on the effects on the ability to drive and use machines have been performed.
Študije o vplivu na sposobnost vožnje in upravljanja s stroji niso bile izvedene.
Hypersensitive reactions (local rash, contact dermatitis, eczema and angioedema of the lips) may occur.
Možne so preobčutljivostne reakcije (lokalni izpuščaj, kontaktni dermatitis, ekcem in angioedem na ustnicah).
The frequency is not known.
Pogostnost ni znana.
If other adverse reactions not mentioned above occur, a doctor or a qualified healthcare practitioner should be consulted.
Če se pojavijo drugi neželeni učinki, ki niso navedeni zgoraj, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
COMMUNITY LIST ENTRY ON ELEUTHEROCOCCUS SENTICOSUS (RUPR.
VPIS V SEZNAM SKUPNOSTI ELEUTHEROCOCCUS SENTICOSUS (RUPR.
Eleutherococcus root
Korenina elevterokoka
Comminuted herbal substance for preparation of a herbal tea
Zdrobljena rastlinska snov za pripravo zdravilnega čaja
Liquid extract (1:1, ethanol 30-40 % v/v)
Tekoči ekstrakt (1:1, etanol 30–40 % v/v)
Dry extract (13-25: 1, ethanol 28-40 % v/v)
Suhi ekstrakt (13–25:1, etanol 28–40 % v/v)
Dry extract (17-30: 1, ethanol 70 % v/v)
Suhi ekstrakt (17–30:1, etanol 70 % v/v)
Dry aqueous extract (15-17:1)
Suhi vodni ekstrakt (15–17:1)
Tincture (1:5, ethanol 40 % v/v)
Tinktura (1:5, etanol 40 % v/v)
Eleutherococcus — Eleutherococci radix (ref.: 01/2008: 1419 corrected 6.0)
Eleutherococcus – Eleutherococci radix (sklic: 01/2008: 1419 popravljen 6.0)
Traditional herbal medicinal product for symptoms of asthenia such as fatigue and weakness.
Tradicionalno zdravilo rastlinskega izvora za zdravljenje simptomov astenije, kot sta utrujenost in oslabelost.
Chinese, European.
kitajska, evropska
Adolescents over 12 years of age, adults, elderly
Mladostniki nad 12 let, odrasli, starejši
Herbal preparations.
Pripravki rastlinskega izvora
Daily dose.
Dnevni odmerek
Comminuted herbal substance as herbal tea: 0,5-4 g.
Zdrobljena rastlinska snov kot zdravilni čaj: 0,5–4 g
Tea preparation: 0,5 to 4 g of comminuted herbal substance for infusion in 150 ml of boiling water.
Priprava čaja: 0,5 do 4 g zdrobljene rastlinske snovi za pripravo poparka v 150 ml vode.
Dosage frequency: 150 ml of tea infusion should be divided in one to three doses taken during the day.
Pogostost odmerjanja: 150 ml čajnega poparka se razdeli na enega do tri dnevne odmerke.
Liquid extract: 2-3 ml.
Tekoči ekstrakt: 2–3 ml
Dry extracts (ethanol 28-70 % v/v) corresponding to 0,5-4 g dried root.
Suhi ekstrakti (etanol 28–70 % v/v) ustrezajo 0,5–4 g posušene korenine.
Dry aqueous extract (15-17:1): 90-180 mg.
Suhi vodni ekstrakt (15–17:1): 90–180 mg
Tincture: 10-15 ml.
Tinktura: 10–15 ml
The daily dose can be taken in one to three doses.
Dnevni odmerek se lahko zaužije v enem do treh odmerkih.
The use is not recommended in children under 12 years of age (see below “Special warnings and precautions for use”).
Uporaba pri otrocih, mlajših od 12 let, ni priporočljiva (glej poglavje ‚Posebna opozorila in previdnostni ukrepi‘).
Not to be taken for more than 2 months.
Zdravilo se ne sme uporabljati več kot 2 meseca.
If the symptoms persist for more than 2 weeks during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.
Če simptomi med uporabo zdravila po 2 tednih ne popustijo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
Hypersensitivity to the active substance.
Preobčutljivost na zdravilno učinkovino.
Arterial hypertension.
Arterijska hipertenzija (zvišan krvni tlak).
The use in children under 12 years of age is not recommended because sufficient experience is not available.
Uporaba pri otrocih, mlajših od 12 let, ni priporočljiva, ker ni na voljo zadostnih izkušenj.
If the symptoms worsen during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted.
Če se simptomi med uporabo zdravila poslabšajo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
Insomnia, irritability, tachycardia and headaches may occur.
Pojavijo se lahko nespečnost, razdražljivost, tahikardija (zvišan srčni utrip) in glavoboli.
No case of overdose has been reported.’
Ni poročil o primerih prevelikega odmerjanja.“
appointing three Belgian members and two Belgian alternate members of the Committee of the Regions
o imenovanju treh belgijskih članov in dveh belgijskih nadomestnih članov Odbora regij
Three members’ seats on the Committee of the Regions have become vacant following the end of the term of office of Mr Geert BOURGEOIS, Mr Dirk VAN MECHELEN and Mr Jos CHABERT.
Zaradi izteka mandatov Geerta BOURGEOISA, Dirka VAN MECHELNA in Josa CHABERTA so se sprostila tri mesta članov Odbora regij.
Two alternate members’ seats have become vacant following the end of the term of office of Ms Evelyne HUYTEBROECK and Mr Pascal SMET,
Zaradi izteka mandatov Evelyne HUYTEBROECK in Pascala SMETA sta se sprostili dve mesti nadomestnih članov –
The following are hereby (re)appointed to the Committee of the Regions for the remainder of the current term of office, which runs until 25 January 2010:
Za preostanek mandata, ki se izteče 25. januarja 2010, se v Odbor regij (ponovno) imenujejo:
Mr Geert BOURGEOIS, viceminister-president van de Vlaamse Regering en Vlaams Minister van Bestuurszaken, Binnenlands Bestuur, Inburgering, Toerisme en Vlaamse Rand (change of mandate),
Geert BOURGEOIS, viceminister-president van de Vlaamse Regering en Vlaams Minister van Bestuurszaken, Binnenlands Bestuur, Inburgering, Toerisme en Vlaamse Rand (sprememba mandata),
Mr Dirk VAN MECHELEN, Vlaams volksvertegenwoordiger (change of mandate),
Dirk VAN MECHELEN, Vlaams volksvertegenwoordiger (sprememba mandata),
Mr Jos CHABERT, opvolger in het Brussels Parlement (change of mandate),
Jos CHABERT, opvolger in het Brussels Parlement (sprememba mandata),
of 20 December 2010
z dne 20. decembra 2010
concerning the opening of accounts for the processing of payments in connection with EFSF loans to Member States whose currency is the euro
o odprtju računov za obdelavo plačil v povezavi s posojili družbe EFSF državam članicam, katerih valuta je euro
Having regard to the Statute of the European System of Central Banks and of the European Central Bank, and in particular Articles 17 and 21 thereof,
ob upoštevanju Statuta Evropskega sistema centralnih bank in Evropske centralne banke ter zlasti njegovih členov 17 in 21,
Pursuant to Article 17 of the Statute of the European System of Central Banks and of the European Central Bank (hereinafter the ‘Statute of the ESCB’), in order to conduct its operations, the European Central Bank (ECB) may open accounts for credit institutions, public entities and other market participants.
V skladu s členom 17 Statuta Evropskega sistema centralnih bank in Evropske centralne banke (v nadaljnjem besedilu: Statut ESCB) lahko Evropska centralna banka (ECB) za opravljanje svojega poslovanja odpira račune za kreditne institucije, osebe javnega prava in druge udeležence na trgu.